Find your path to Kyle
107 people in our graph share verified history with Kyle — schools, employers, funds. One of them is your warm intro.
About
Kyle Jackson is an Associate at Celesta Capital, focusing on deeptech and life sciences investment. He holds a PhD in Chemical Engineering from McMaster University, where his research addressed bacteriophage-based therapeutics for IBD and other gastrointestinal conditions, and has previously held roles at Amplitude Ventures, Bloom Burton & Co., HaloHealth, and Front Row Ventures, conducting due diligence on over 300 biotech and medtech startups. He has also co-founded two startups, one developing an AI-driven drug discovery platform and another building a remote monitoring device for congestive heart failure.
Experience
- Celesta CapitalAssociatecurrent2026 — presentToronto, Ontario, Canada
- The Clinic | DeGroote Heersink HubBusiness Development Officer2025 — 2026Toronto, Ontario, Canada
- The Clinic | DeGroote Heersink HubStart-up Advisor2022 — 2025Hamilton, Ontario, Canada
- Pre-AmpConsultant2024 — 2026Toronto, Ontario, Canada
- Pre-AmpFellow2024Toronto, Ontario, Canada
- Front Row VenturesConsultant2024 — 2025
- Front Row VenturesDirector of Investments, ONT2023 — 2024Toronto, Ontario, Canada
- Front Row VenturesInvestment Team2022 — 2023Toronto, Ontario, Canada
- HaloHealthAnalyst2023 — 2024Toronto, Ontario, Canada
- HaloHealthVenture Fellow2022 — 2023Hamilton, Ontario, Canada
- Bloom Burton & Co.Scientific Consultant2023 — 2024Toronto, Ontario, Canada
- McMaster SynBioProject Manager2020 — 2023Hamilton, Ontario, Canada
- Phage DirectoryColumn Contributor2021 — 2023
- McMaster-Janssen Diverse Future Leaders ProgramMcMaster-Janssen Leadership Fellow2022Hamilton, Ontario, Canada
- Tenomix Inc.Business Development Consultant2022Hamilton, Ontario, Canada
- McMaster UniversityGraduate Teaching Assistant2021Hamilton, Ontario, Canada
- KardioSmartStrategic Business Development Consultant2020 — 2021Hamilton, Ontario, Canada
- McMaster UniversityGraduate Teaching Assistant2020
- Biohybrids LabUndergraduate Research Assistant | NSERC USRA2019 — 2020McMaster University
- Biohybrids LabThesis Student2019 — 2020McMaster University
- McMaster NEUDOSEOperations Manager & Co-Project Manager2018 — 2020McMaster University
- McMaster NEUDOSETeam Lead - Payload Data and Systems Analysis2017 — 2018McMaster Univeristy
- Toronto High Park FCSenior Referee2010 — 2019Greater Toronto Area, Canada
Skills & more
+12 more
Due DiligenceMedical TechnologyBiotechnologyMedical DevicesMolecular BiologyDrug InteractionsClinical ResearchPharmacologyBusiness StrategyFirst AidCardiopulmonary Resuscitation (CPR)Time Management- Space Biotechnology — Titan | Disruptive Innovation Center🇨🇭
- Health Venture Program — McMaster University
- The Venture Capital Blueprint — Front Row Ventures
From Kyle's professional profile.
Colleagues at Celesta Capital
Frequently asked questions
- Who is Kyle Jackson?
- Kyle Jackson is an Associate at Celesta Capital, focusing on deeptech and life sciences investment. He holds a PhD in Chemical Engineering from McMaster University, where his research addressed bacteriophage-based therapeutics for IBD and other gastrointestinal conditions, and has previously held roles at Amplitude Ventures, Bloom Burton & Co., HaloHealth, and Front Row Ventures, conducting due diligence on over 300 biotech and medtech startups. He has also co-founded two startups, one developing an AI-driven drug discovery platform and another building a remote monitoring device for congestive heart failure.
- Where does Kyle Jackson work?
- Kyle Jackson is Associate at Celesta Capital.
- Where did Kyle Jackson go to school?
- Kyle Jackson studied at McMaster University (Doctor of Philosophy - PhD, Bioengineering, Biomedical Engineering, and Gastroenterology); McMaster University (Bachelor of Health Sciences, Biomedical Discovery and Commercialization).
Same school
Also attended McMaster University148
+ 142 more
Shared employers
Also worked at The Clinic | DeGroote Heersink Hub1
Also worked at Front Row Ventures22
+ 16 more












.avif)






















